NC
PFE icon

Northpointe Capital’s Pfizer PFE Stock Holding History

Northpointe Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-88,044
Closed -$3.62M – 101
2019
Q2 		$3.62M Sell
88,044
-117,904
-57% -$4.68M 1.15% 36
2019
Q1 		$8.3M Buy
205,948
+85,543
+71% +$3.43M 2.61% 5
2018
Q4 		$4.99M Sell
120,405
-95,595
-44% -$3.97M 1.13% 14
2018
Q3 		$9.03M Sell
216,000
-2,259
-1% -$87K 1.3% 9
2018
Q2 		$7.51M Sell
218,259
-24,023
-10% -$821K 1% 26
2018
Q1 		$8.16M Sell
242,282
-6,044
-2% -$208K 1.02% 27
2017
Q4 		$8.53M Buy
248,326
+87,763
+55% +$2.99M 0.96% 28
2017
Q3 		$5.44M Buy
160,563
+7,160
+5% +$230K 0.58% 61
2017
Q2 		$4.89M Buy
153,403
+6,718
+5% +$212K 0.51% 80
2017
Q1 		$4.76M Buy
146,685
+51
+0% +$1.61K 0.52% 68
2016
Q4 		$4.52M Sell
146,634
-131,213
-47% -$4.01M 0.45% 73
2016
Q3 		$8.93M Buy
277,847
+11,810
+4% +$395K 0.93% 32
2016
Q2 		$8.89M Buy
266,037
+115,429
+77% +$3.68M 1.05% 31
2016
Q1 		$4.24M Sell
150,608
-87,171
-37% -$2.49M 0.53% 64
2015
Q4 		$7.09M Hold
237,779
– – 0.93% 37
2015
Q3 		$7.09M Buy
237,779
+127,882
+116% +$4.1M 0.92% 37
2015
Q2 		$3.5M Buy
109,897
+18,077
+20% +$589K 0.41% 77
2015
Q1 		$3.03M Buy
91,820
+6,408
+8% +$204K 0.33% 97
2014
Q4 		$2.52M Sell
85,412
-38,499
-31% -$1.1M 0.3% 112
2014
Q3 		$3.48M Buy
123,911
+783
+0.6% +$22K 0.37% 84
2014
Q2 		$3.47M Buy
123,128
+75,986
+161% +$2.17M 0.33% 88
2014
Q1 		$1.44M Sell
47,142
-48,997
-51% -$1.46M 0.15% 150
2013
Q4 		$2.79M Sell
96,139
-19,288
-17% -$561K 0.25% 96
2013
Q3 		$3.15M Buy
115,427
+60,061
+108% +$1.63M 0.37% 79
2013
Q2 		$1.47M Buy
+55,366
New +$1.53M 0.17% 126

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northpointe Capital's PFE Position: Q3 2019 in Review

Northpointe Capital sold out of Pfizer (PFE) in Q3 2019, closing a stake of 88,044 shares — an estimated $3.62M sold.

Northpointe Capital first reported a position in PFE in Q2 2013 and held it in 25 quarters. The position peaked at $9.03M in Q3 2018. 2,322 funds tracked by Wall St. Rank hold PFE as of Q3 2019.

  • Northpointe Capital reported no remaining Pfizer position as of Q3 2019 after selling out during the quarter.
  • Northpointe Capital sold 88,044 Pfizer shares in Q3 2019, an estimated $3.62M.
  • Northpointe Capital first reported a position in Pfizer in Q2 2013 and held it in 25 quarters.
  • Northpointe Capital's Pfizer position peaked at $9.03M in Q3 2018.
  • 2,322 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.

Based on Northpointe Capital's 13F filing for Q3 2019, filed 16 Oct 2019.